SeaStar Medical (NASDAQ:ICU – Get Free Report) and Orthofix Medical (NASDAQ:OFIX – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership.
Profitability
This table compares SeaStar Medical and Orthofix Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SeaStar Medical | -795.51% | -162.75% | -109.89% |
| Orthofix Medical | -7.41% | -14.05% | -7.17% |
Analyst Recommendations
This is a summary of recent recommendations and price targets for SeaStar Medical and Orthofix Medical, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SeaStar Medical | 1 | 0 | 1 | 0 | 2.00 |
| Orthofix Medical | 1 | 1 | 3 | 0 | 2.40 |
SeaStar Medical currently has a consensus price target of $8.00, indicating a potential upside of 165.78%. Orthofix Medical has a consensus price target of $14.75, indicating a potential upside of 57.33%. Given SeaStar Medical’s higher possible upside, analysts clearly believe SeaStar Medical is more favorable than Orthofix Medical.
Volatility and Risk
SeaStar Medical has a beta of -1.09, suggesting that its stock price is 209% less volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 0.62, suggesting that its stock price is 38% less volatile than the S&P 500.
Institutional & Insider Ownership
1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by insiders. Comparatively, 2.7% of Orthofix Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Valuation and Earnings
This table compares SeaStar Medical and Orthofix Medical”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SeaStar Medical | $1.71 million | 7.74 | -$12.15 million | ($3.91) | -0.77 |
| Orthofix Medical | $822.31 million | 0.46 | -$92.19 million | ($1.54) | -6.09 |
SeaStar Medical has higher earnings, but lower revenue than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.
Summary
Orthofix Medical beats SeaStar Medical on 10 of the 14 factors compared between the two stocks.
About SeaStar Medical
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
About Orthofix Medical
Orthofix Medical Inc. operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations. The Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Receive News & Ratings for SeaStar Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SeaStar Medical and related companies with MarketBeat.com's FREE daily email newsletter.
